TraceLink, helping the pharma industry trace and track drugs, lands $51.5M from Goldman Sachs
TraceLink, the SaaS platform for tracking and tracing pharmaceuticals, has today announced the close of a $51.5 million Series C financing led by Goldman Sachs Growth Equity. Existing investors, such as FirstMark Capital, Volition Capital, and F-Prime Capital, also participated in the round.
As part of the deal, Goldman’s Jason Kreuziger is joining TraceLink’s board of directors.
TraceLink was founded in 2009 with the introduction of the Life Sciences Cloud, a suite of SaaS applications that are natively integrated with AWS. The Life Sciences Cloud allows pharmaceutical businesses to comply with country-specific track and trace requirements throughout their supply chain.Read the full article on TechCrunch